Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| XERS | McCulloch Kevin | See Remarks | 11/05/2026 | Verkauf | 12.49 | 25,000 | 312,215 | Form 4 |
| XEL | Frenzel Robert | Chairman, President and CEO | 11/04/2026 | Schenkung | — | 142,288 | — | Form 4 |
| XEL | Frenzel Robert | Chairman, President and CEO | 11/04/2026 | Schenkung | — | 1,350 | — | Form 4 |
| XERS | Pieper Steven | See Remarks | 11/02/2026 | Verkauf | 10.23 | 5,000 | 51,174 | Form 4 |
| XERS | Hecht Beth | See Remarks | 11/02/2026 | Verkauf | 10.23 | 25,000 | 255,828 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 11/02/2026 | Verkauf | 10.23 | 15,000 | 153,488 | Form 4 |
| XERS | Taddese Menassie | Director | 11/02/2026 | Zuteilung | — | 22,365 | — | Form 4 |
| XE | Ghaffarian Kamal Seyed | Director | 11/02/2026 | J | — | 108,174 | — | Form 4 |
| XENE | Kelly Thomas Patrick | Chief Financial Officer | 10/15/2026 | Optionsausübung | — | 7,500 | — | Form 4 |
| XERS | Pieper Steven | See Remarks | 10/01/2026 | Verkauf | 9.41 | 5,000 | 47,037 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 10/01/2026 | Verkauf | 9.41 | 15,000 | 141,120 | Form 4 |
| XERS | Hecht Beth | See Remarks | 10/01/2026 | Verkauf | 9.41 | 16,666 | 156,792 | Form 4 |
| XENE | Kelly Thomas Patrick | Chief Financial Officer | 09/30/2026 | Kauf | 37.32 | 15,000 | 559,740 | Form 4 |
| XENE | Mortimer Ian | PRESIDENT & CEO | 09/30/2026 | Kauf | 37.38 | 30,000 | 1,121,400 | Form 4 |
| XEL | Carter Peter W | Director | 09/28/2026 | Zuteilung | — | 404 | — | Form 4 |
| XEL | Burkhart Megan D | Director | 09/28/2026 | Zuteilung | — | 688 | — | Form 4 |
| XEL | Kampling Patricia L | Director | 09/28/2026 | Zuteilung | — | 774 | — | Form 4 |
| XEL | Pardee Charles G | Director | 09/28/2026 | Zuteilung | — | 666 | — | Form 4 |
| XEL | Welsh Timothy A | Director | 09/28/2026 | Zuteilung | — | 580 | — | Form 4 |
| XEL | Casey Lynn | Director | 09/28/2026 | Zuteilung | — | 580 | — | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 09/28/2026 | Verkauf | 10.00 | 25,000 | 250,000 | Form 4 |
| XENE | Svoronos Dawn | Director | 09/01/2026 | Optionsausübung | 8.15 | 5,144 | 41,924 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 09/01/2026 | Verkauf | 8.49 | 15,000 | 127,308 | Form 4 |
| XERS | Pieper Steven | See Remarks | 09/01/2026 | Verkauf | 8.50 | 5,000 | 42,500 | Form 4 |
| XERS | Hecht Beth | See Remarks | 09/01/2026 | Verkauf | 8.49 | 16,666 | 141,434 | Form 4 |
| XENE | Kenney Christopher John | Chief Medical Officer | 08/28/2026 | Verkauf | 60.98 | 700 | 42,684 | Form 4 |
| XENE | Kenney Christopher John | Chief Medical Officer | 08/28/2026 | Verkauf | 60.17 | 6,368 | 383,145 | Form 4 |
| XERS | Pieper Steven | See Remarks | 08/12/2026 | Verkauf | 8.50 | 5,000 | 42,500 | Form 4 |
| XENE | Gannon Steven | Director | 08/11/2026 | Verkauf | 64.06 | 10,000 | 640,550 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 08/03/2026 | Verkauf | 8.02 | 15,000 | 120,240 | Form 4 |
| XERS | Hecht Beth | See Remarks | 08/03/2026 | Verkauf | 8.01 | 16,666 | 133,553 | Form 4 |
| XERS | Shannon John Patrick Jr | See Remarks | 08/01/2026 | Steuer-Abgabe | 8.08 | 36,645 | 296,092 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 08/01/2026 | Steuer-Abgabe | 8.08 | 21,918 | 177,097 | Form 4 |
| XEL | Carter Peter W | Director | 07/29/2026 | Zuteilung | — | 1,819 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).